Regeneron Pharmaceuticals Inc 2024-06-05 Health serious FDA
Health · FDA · Recall #FDA-D-0531-2024
EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL… Recall
Issued June 5, 2024 · Regeneron Pharmaceuticals Inc
In June 2024, Regeneron Pharmaceuticals Inc recalled the EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility: Complaints of syringe breakage
What you should do
- 1 Stop using EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Regeneron Pharmaceuticals Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Regeneron Pharmaceuticals Inc
- Category
- Health
- Recall date
- June 5, 2024
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0531-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Regeneron Pharmaceuticals Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.